PTC Therapeutics director Michael Schmertzler disposes of common shares worth $1.34 million
PTCT•Director reports common share sales
PTC Therapeutics director Michael Schmertzler reported sales of 20,000 common shares on Sep. 16-17.
Sales were priced at $66.58 to $68.45 per share.
Indirect holdings were listed at 1,296,594 shares following the transactions.
